Longevity News

Lactylation: A Metabolic-Epigenetic Driver in Atherosclerosis Pathogenesis and Therapeutic Targeting

Source: Frontiers - Health • Published: 10 Jun 2026, 00:00

Lactylation: A Metabolic-Epigenetic Driver in Atherosclerosis Pathogenesis and Therapeutic Targeting

Review examines how a novel metabolic-epigenetic modification shapes atherosclerosis mechanisms and highlights near-term therapeutic targeting opportunities.

Key Takeaways
  • You have multiple emails registered with Frontiers: You don't have a Frontiers account ?
  • Previous studies suggest that lactylation plays a vital part in AS development
  • Further elucidation of lactylation may provide novel mechanistic insights into AS development
Read Original Source